HEARTLINE HSM Genoa Cardiology Meeting - Aristea

Yan AT, Yan RT, Tan M, et al. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratied
by the GRACE risk score. Am J Cardiol 200 ;96:91 –916.
-Lagerqvist B, Husted S, Kontny F, et al. -year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive
strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 2006; 68:998–100 .
-Damman P, Hirsch A, Windhausen F et al,. -year clinicaloutcomes in the ICTUS (Invasive versus Conservative Treatment in
Unstablecoronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients
with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol 2010; :8 8–86 .
-Fox KA, Poole-Wilson P, Clayton TC, et al. -year outcome of an interventional strategy in non-ST-elevation acute coronary
syndrome: the British Heart Foundation RITA randomised trial. Lancet 200 ; 66:91 –920.
-Giugliano RP, White JA, Bode C, et al. Early versus delayed, provisional eptibatide in acute coronary syndromes. N Engl J Med
2009; 60: 2176–2190.
-Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med
2009; 60:216 –217 .
-Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a
quantitative review of 2 randomised trials. Lancet 200 ; 61:1 –20.
-Kalla K, Christ G, Karnik R, et al. Implementation of guidelines improves the standard of care: Viennese registry on reperfusion
strategies in ST-elevation myocardial infarction (Vienna STEMI registry).Circulation 2006;11 :2 98–2 0 .
-Zahn R, Schiele R, Schneider S, et al. Decreasing hospital mortality between 199 and 1998 in patients with acute myocardial
infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled
data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR).
J Am Coll Cardiol 2000; 6:206 –2071.
-Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 200 guideline update for percutaneous coronary intervention: a
report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing
Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;11 :e166–e286.
-Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after brinolysis for acute myocardial infarction. N Engl J
Med 2009; 60:270 –2718.
-Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis
in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective,
randomised, multicentre trial. Lancet 2008; 71: 9– 68.
-Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 2 hours of thrombolysis versus ischaemiaguided
conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.
Lancet 200 ; 6 :10 –10 .
-Gershlick AH, Stephens-Lloyd A, Hughes S, et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial
infarction. N Engl J Med 200 ; :27 8–2768.
-Bonnefoy E, Steg PG, Boutitie F, et al.Comparison of primary angioplasty and pre-hospital brinolysis in acute myocardial infarction
(CAPTIM) trial: a -year follow-up. Eur Heart J 2009; 0:1 98–1606.
-Widimsky P, Wijns W, Fajadet J et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of
the current situation in 0 countries. Eur Heart J 2010; 1:9 –9 7.
-Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary
intervention and in-hospital brinolysis in acute myocardial infarction patients. Eur Heart J 2006;27:779–788.
-Nallamothu B, Fox KA, Kennelly BM, et al. Relationship of treatment delays and mortality in patients undergoing brinolysis and
primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events.
Heart 2007;9 :1 2–1 .
-Ellis SG, Tendera M, de Belder MA, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med
2008; 8:220 –2217.
-Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, et al. Rescue angioplasty or repeat brinolysis after failed brinolytic therapy
for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol 2007; 9: 22– 0.
-Busk M, Kaltoft A, Nielsen SS, et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with
symptoms for ,12 h vs. 12–72 h. Eur Heart J 2009; 0:1 22–1 0.
-Schomig A, Mehilli J,Antoniucci D, Ndrepepa G,. Mechanical ESC/EACTS Guidelines 2 9reperfusion in patients with acute myocardial
infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 200 ;29 :286 –2872.
-Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med
2006; :2 9 –2 07.
-Steg PG, Thuaire C, Himbert D, et al. DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of
occluded artery angioplasty after acute myocardial infarction. Eur Heart J 200 ;2 :2187–219 .
-Weiss ES, Chang DD, Joyce DL, et al. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of
California discharge data. J Thorac Cardiovasc Surg 2008;1 : 0 – 11.
-Montalescot G, Wiviott SD, Braunwald E, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary
intervention for ST-elevation myocardial infarction (TRITONTIMI 8): double-blind, randomised controlled trial. Lancet
2009; 7 :72 –7 1.
-Cannon CP, Harrington RA, James S, et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy
for acute coronary syndromes (PLATO): a randomized double-blind study. Lancet 2010; 7 :28 –29 .
-Huber K, Holmes DR Jr, van ’t Hof AW, et al. Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention:
insights from the APEX-AMI trial. Eur Heart J 2010; 1;1708–1716.
9